Monterey Bio Acquisition Corporation – NASDAQ:MTRY

Financial Health
0
1
2
3
4
5
6
7
8
9

Monterey Bio Acquisition stock price monthly change

-1.07%
month

Monterey Bio Acquisition stock price quarterly change

-0.54%
quarter

Monterey Bio Acquisition stock price yearly change

+8.89%
year

Monterey Bio Acquisition key metrics

Market Cap
 48.30M
Enterprise value
 N/A
P/E
 -33.37
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 1.53
PEG ratio
 767.04
EPS
 -0.20
Revenue
 N/A
EBITDA
 -2.03M
Income
 -1.03M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Monterey Bio Acquisition stock price history

Monterey Bio Acquisition stock forecast

Monterey Bio Acquisition financial statements

Profit Margin

Monterey Bio Acquisition Corporation (NASDAQ:MTRY): Profit margin
Sep 2022 0 -420.49K
Dec 2022 0 -307.12K
Mar 2023 0 -152.25K
Jun 2023 0 -151.48K
MTRY income statement history

Debt to Assets

Monterey Bio Acquisition Corporation (NASDAQ:MTRY): Debt to assets
Sep 2022 117469001 97.42M 82.93%
Dec 2022 21418521 1.67M 7.83%
Mar 2023 21872125 2.28M 10.44%
Jun 2023 22413220 2.97M 13.28%
MTRY balance sheet history

Cash Flow

Monterey Bio Acquisition Corporation (NASDAQ:MTRY): Cash Flow
Sep 2022 -121.34K 299 361.44K
Dec 2022 -387.04K 95.70M -95.71M
Mar 2023 -132.52K -237.97K 443.09K
Jun 2023 -340.24K -114.83K 776.46K
MTRY cash flow history

Monterey Bio Acquisition other data

Monterey Bio Acquisition
Hedge Funds Holdings Q1 2023

37.39% -28.80%
of MTRY is owned by hedge funds
4 -13
hedge funds hold MTRY stock
1.03M -797.24K
shares is hold by hedge funds
MTRY hedge funds holdings changes

Monterey Bio Acquisition
Insider Trading

Monterey Bio Acquisition Corporation (NASDAQ:MTRY): Insider trades (number of shares)
Period Buy Sel
Mar 2023 956250 1166250
Transaction Date Insider Security Shares Price per share Total value Source
Sale
GROSSMAN JONAS director, 10 perc.. Common Stock 13,125 $0.01 $79
Purchase
GROSSMAN JONAS director, 10 perc.. Common Stock 478,125 $0.01 $2,869
Sale
NORTHSTAR BIO VENTURES, LLC 10 percent owner
 Common Stock 570,000 $0.01 $3,420
Sale
CHARDAN MONTEREY INVESTMENTS LLC 10 percent owner
 Common Stock 13,125 $0.01 $79
Purchase
CHARDAN MONTEREY INVESTMENTS LLC 10 percent owner
 Common Stock 478,125 $0.01 $2,869
Sale
PATEL SANDIP I director, 10 percent owner:
Common Stock 570,000 $0.01 $3,420
MTRY insider trading transactions

Frequently Asked Questions (FAQ)

  • When is Monterey Bio Acquisition's next earnings date?

    Unfortunately, Monterey Bio Acquisition's (MTRY) next earnings date is currently unknown.

  • Does Monterey Bio Acquisition pay dividends?

    No, Monterey Bio Acquisition does not pay dividends.

  • How much money does Monterey Bio Acquisition make?

    Monterey Bio Acquisition has a market capitalization of 48.30M.

  • What is Monterey Bio Acquisition's stock symbol?

    Monterey Bio Acquisition Corporation is traded on the NASDAQ under the ticker symbol "MTRY".

  • What is Monterey Bio Acquisition's primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Monterey Bio Acquisition?

    Shares of Monterey Bio Acquisition can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Monterey Bio Acquisition went public?

    Monterey Bio Acquisition Corporation is publicly traded company for more then 3 years since IPO on 22 Nov 2021.

  • What is Monterey Bio Acquisition's official website?

    The official website for Monterey Bio Acquisition is montereybio.com.

  • Where are Monterey Bio Acquisition's headquarters?

    Monterey Bio Acquisition is headquartered at 17 State Street, New York, NY.

  • How can i contact Monterey Bio Acquisition?

    Monterey Bio Acquisition's mailing address is 17 State Street, New York, NY and company can be reached via phone at +91 72670216.

Monterey Bio Acquisition company profile:

Monterey Bio Acquisition Corporation

montereybio.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.

+91 72670216
17 State Street
New York, NY 10004

CIK: 0001860663
ISIN: US61240F1084
CUSIP: 61240F108